Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02154 |
Pyrromycin (668-17-7) Inquiry |
|
It is an antibiotic against gram-positive bacteria originally isolated from Str. sp. DOA 1205. |
||
BBF-02155 | ||
Pyrronamycin A is produced by the strain of Streptomyces sp. KY11768. It has antibacterial activity against gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella. |
||
BBF-02156 | ||
Pyrronamycin B is produced by the strain of Streptomyces sp. KY11768. It has antibacterial activity against gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella. It also has anti-tumor activity. |
||
BBF-02157 | ||
Isoquinocycline A is originally isolated from Str. aureofaciens. It has strong anti-mycobacterium activity. |
||
BBF-02158 |
Quadrilineatin (642-27-3) Inquiry |
|
It is originally isolated from Asp. quadrilineatus NRRL 521, NRRL 201, SM 200, SM-297, GA317. Quadrilineatin has antifungal and bacterial effects. |
||
BBF-02160 | ||
Queenslandon is produced by the strain of Chrysosporium queenslandicum IFM 51121. It has moderate anti-streptomyces, penicillium, Penicillium, Aspergillus fumigatus, aspergillus flavus and other fungal activities. And it has no effect on bacteria. |
||
BBF-02165 |
Quinomycin C (11001-74-4) Inquiry |
|
Quinomycin C is originally isolated from Str. sp. 732. It has a strong effect on gram-positive bacteria and HeLa cells, and also on some gram-negative bacteria. It also has a protective effect on mice inoculated with poliovirus. |
||
BBF-02166 |
Quinomycin B (13602-52-3) Inquiry |
|
Quinomycin B is originally isolated from Str. sp. 732. It has a strong effect on gram-positive bacteria and HeLa cells, and also on some gram-negative bacteria. It also has a protective effect on mice inoculated with poliovirus. |
||
BBF-02167 | ||
Rabelomycin is originally isolated from Str.olivaceus. Rabelomycin only works against gram-positive bacteria. |
||
BBF-02168 |
Racemomycin A (3808-42-2) Inquiry |
|
It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture. |
||
BBF-02169 |
Racemomycin B (3776-37-2) Inquiry |
|
It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture. |
||
BBF-02170 |
Racemomycin C (3776-38-3) Inquiry |
|
It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture. |
||
BBF-02171 |
Racemomycin D (3776-36-1) Inquiry |
|
It is produced by the strain of Str. racemochromogenes 229. It has broad spectrum antibacterial activity and antifungal effect, and it can inhibit PR-8 of influenza virus in tissue culture. |
||
BBF-02172 | ||
Radicinin is produced by the strain of Curvularia lunata IAM-18010. It has anti-bacterial effect, but its activity is weak. |
||
BBF-02173 | ||
Rakicidin A is originally isolated from Micromonospora sp. R385-2. It has anti-tumor activity in vitro with the IC50 of 40 μg/mL. |
||
BBF-02174 | ||
Rakicidin B is originally isolated from Micromonospora sp. R385-2. It has anti-tumor activity in vitro with the IC50 of 200 μg/mL. |
||
BBF-02175 | ||
It is produced by the strain of Pestalotia ramulosa NRRL 2826. Ramulosin has an antifungal effect and inhibits the germination of fungal meristems. |
||
BBF-02176 |
Rancinamycin III (60925-60-2) Inquiry |
|
Rancinamycin III is an antibiotic that has antibacterial properties originally isolated from Str. lincolnensis. |
||
BBF-02178 | ||
It is produced by the strain of Streptomyces sp. GW71/2497. Resomycin A showed activity of anti-staphylococcus aureus, Escherichia coli and Streptomyces green, with MIC of about 20 μg/mL. |
||
BBF-02179 | ||
It is produced by the strain of Streptomyces sp. GW71/2497. Resomycin B showed activity of anti-staphylococcus aureus, Escherichia coli and Streptomyces green, with MIC of about 20 μg/mL. |